Viewing Study NCT00083694


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-05-23 @ 7:55 AM
Study NCT ID: NCT00083694
Status: COMPLETED
Last Update Posted: 2010-07-02
First Post: 2004-05-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia
Sponsor: University of Arkansas
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module